TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 21261935

Group type: EXPERIMENTAL
Intervention: Phone group (behavior counseling by phone)
Number of subjects: 276

Group type: EXPERIMENTAL
Intervention: Internet group (behavior counseling by e‐mail)
Number of subjects: 276

Group type: COMPARATOR
Intervention: Control group (usual care)
Number of subjects: 276
Study: 19300037

Group type: EXPERIMENTAL
Intervention: Piclozotan
Number of subjects: 158
Study: 17376233

Group type: EXPERIMENTAL
Intervention: Guideline-based composite measure of totally controlled (TC) asthma
Number of subjects: 3416

Group type: EXPERIMENTAL
Intervention: Guideline-based composite measure of well controlled (WC) asthma
Number of subjects: 3416

Group type: EXPERIMENTAL
Intervention: Reference criteria: Forced expiratory volume in 1 second (FEV1)
Number of subjects: 3416

Group type: EXPERIMENTAL
Intervention: Reference criteria: Asthma Quality of Life Questionnaire (AQLQ)
Number of subjects: 3416

Group type: EXPERIMENTAL
Intervention: Guideline-based composite measures (TC and WC)
Number of subjects: 3416
Study: 15248820

Group type: EXPERIMENTAL
Intervention: Growth Hormone (1.7 microg/kg per day)
Number of subjects: 12

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 12
Study: 11687541

Group type: EXPERIMENTAL
Intervention: Endothelin (ET)-1 at 5 ng/kg x min with BQ123 (60 microg/kg x min)
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: BQ123 at 60 microg/kg x min
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: BQ123 at 120 microg/kg x min
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: Endothelin (ET)-1 at 2.5 ng/kg x min or higher with BQ123
Number of subjects: 24

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 24
Study: 9159303

Group type: EXPERIMENTAL
Intervention: Cancer antigen 125 (CA125) measurement in peritoneal dialysis effluent (PDE)
Number of subjects: 76

Group type: EXPERIMENTAL
Intervention: Cancer antigen 125 (CA125) measurement in PDE
Number of subjects: 76

Group type: EXPERIMENTAL
Intervention: History of peritonitis and duration of CAPD
Number of subjects: 76

Group type: EXPERIMENTAL
Intervention: Use of hypertonic dialysate in small-volume CAPD (3 x 2 L daily exchange)
Number of subjects: 76
Study: 8254063

Group type: EXPERIMENTAL
Intervention: Massage therapy (N = 15)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Control group (N = 15)
Number of subjects: 30
Study: 3425219

Group type: EXPERIMENTAL
Intervention: Intrarectal administration of diazepam
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Intrarectal administration of midazolam
Number of subjects: 0

Group type: COMPARATOR
Intervention: Intramuscular administration of diazepam
Number of subjects: 0
Study: 31495010

Group type: EXPERIMENTAL
Intervention: Quality of Nursing Work Life (QNWL)
Number of subjects: 400

Group type: EXPERIMENTAL
Intervention: Non-Saudi nationality, higher age, more work experience, married status, full-time employment, rotating shift, specialty units
Number of subjects: 400
Study: 29165539

Group type: EXPERIMENTAL
Intervention: Self‐management Plus intervention (combined self‐management education, physical activity, and health professional support)
Number of subjects: 145

Group type: COMPARATOR
Intervention: Usual care (control group)
Number of subjects: 145

Group type: EXPERIMENTAL
Intervention: Self‐management Plus intervention
Number of subjects: 145
Study: 25523430

Group type: EXPERIMENTAL
Intervention: 13.3 mg/24 h rivastigmine patch with memantine
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: 13.3 mg/24 h rivastigmine patch alone
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: 4.6 mg/24 h rivastigmine patch with memantine
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: 4.6 mg/24 h rivastigmine patch alone
Number of subjects: 0

Group type: COMPARATOR
Intervention: 13.3 mg/24 h rivastigmine patch
Number of subjects: 0

Group type: COMPARATOR
Intervention: 4.6 mg/24 h rivastigmine patch
Number of subjects: 0
Study: 23475381

Group type: EXPERIMENTAL
Intervention: Anodal transcranial direct current stimulation (tDCS)
Number of subjects: 32

Group type: COMPARATOR
Intervention: Sham stimulation
Number of subjects: 32

Group type: EXPERIMENTAL
Intervention: Anodal tDCS
Number of subjects: 32
Study: 21244493

Group type: EXPERIMENTAL
Intervention: Breastfeeding self‐efficacy intervention
Number of subjects: 150

Group type: COMPARATOR
Intervention: Standard in‐hospital and community care (Control)
Number of subjects: 150
Study: 19497081

Group type: EXPERIMENTAL
Intervention: Performance-based financing (PBF) implemented in health centres
Number of subjects: 159
Study: 16439435

Group type: EXPERIMENTAL
Intervention: Adalimumab
Number of subjects: 10050
Study: 14636332

Group type: EXPERIMENTAL
Intervention: Levetiracetam (LEV)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 10864554

Group type: EXPERIMENTAL
Intervention: Metformin
Number of subjects: 0

Group type: COMPARATOR
Intervention: Sulphonylureas or Insulin
Number of subjects: 0
Study: 8833514

Group type: EXPERIMENTAL
Intervention: Delton light‐polymerized fissure sealant
Number of subjects: 314

Group type: EXPERIMENTAL
Intervention: Duraphat fluoride varnish
Number of subjects: 314

Group type: COMPARATOR
Intervention: Control group (no treatment)
Number of subjects: 314
Study: 1373956

Group type: EXPERIMENTAL
Intervention: Total parenteral nutrition (TPN) with Kcal/g N2 = 100
Number of subjects: 44

Group type: EXPERIMENTAL
Intervention: Total parenteral nutrition (TPN) with Kcal/g N2 = 150
Number of subjects: 44

Group type: EXPERIMENTAL
Intervention: Patients with previous PCM
Number of subjects: 44

Group type: EXPERIMENTAL
Intervention: Patients undergoing EG surgery
Number of subjects: 44

Group type: EXPERIMENTAL
Intervention: Patients with gastrointestinal (GI) surgery
Number of subjects: 44

Group type: EXPERIMENTAL
Intervention: Patients with postoperative septic complications (PSC)
Number of subjects: 44

Group type: EXPERIMENTAL
Intervention: Preoperative values of albumin (A), prealbumin (PA), and total proteins (TP)
Number of subjects: 44
Study: 6487494

Group type: EXPERIMENTAL
Intervention: Trazodone (100 mg) + Ethanol (0.5 ml/kg)
Number of subjects: 6

Group type: EXPERIMENTAL
Intervention: Amitriptyline (50 mg) + Ethanol (0.5 ml/kg)
Number of subjects: 6

Group type: COMPARATOR
Intervention: Ethanol (0.5 ml/kg)
Number of subjects: 6

Group type: COMPARATOR
Intervention: Placebo + Ethanol (0.5 ml/kg)
Number of subjects: 6

Group type: COMPARATOR
Intervention: Trazodone (100 mg)
Number of subjects: 6

Group type: COMPARATOR
Intervention: Amitriptyline (50 mg)
Number of subjects: 6
Study: 30358853

Group type: EXPERIMENTAL
Intervention: Graphic warning labels
Number of subjects: 925

Group type: EXPERIMENTAL
Intervention: Text-only warning labels
Number of subjects: 925

Group type: COMPARATOR
Intervention: Social cue advertisements with the current US Surgeon General's Warning
Number of subjects: 925
Study: 28708705

Group type: COMPARATOR
Intervention: Patient-guided (PG) shock wave treatment
Number of subjects: 74

Group type: EXPERIMENTAL
Intervention: Ultrasound-guided (UG) shock wave treatment
Number of subjects: 74
Study: 25465773

Group type: EXPERIMENTAL
Intervention: DSIG cream
Number of subjects: 130

Group type: COMPARATOR
Intervention: Topical mouth rinse
Number of subjects: 130
Study: 23494116

Group type: EXPERIMENTAL
Intervention: Corticosteroid injection (CSI) with methylprednisolone 1 ml
Number of subjects: 138

Group type: COMPARATOR
Intervention: Local anesthetic injection (LAI) with procaine 1 ml 2%
Number of subjects: 138

Group type: EXPERIMENTAL
Intervention: Corticosteroid injection (CSI)
Number of subjects: 138

Group type: COMPARATOR
Intervention: Local anesthetic injection (LAI)
Number of subjects: 138
Study: 20663113

Group type: EXPERIMENTAL
Intervention: Postoperative quality of life measured using Functional Status Index (FSI), Visual Analogue Score (VAS)‐Fatigue, and Functional Assessment of Cancer Therapy Anemia (FACT‐Anemia) subscale
Number of subjects: 603

Group type: EXPERIMENTAL
Intervention: Change in Hb levels
Number of subjects: 603
Study: 19114224

Group type: EXPERIMENTAL
Intervention: Guggul (2160mg daily for 12 weeks)
Number of subjects: 43

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 43

Group type: EXPERIMENTAL
Intervention: Guggul
Number of subjects: 43
Study: 17548953

Group type: EXPERIMENTAL
Intervention: Palatinose-based balanced formula (PBF)
Number of subjects: 23

Group type: COMPARATOR
Intervention: Control meal
Number of subjects: 23

Group type: EXPERIMENTAL
Intervention: Combined intervention vs control
Number of subjects: 23
Study: 15010623

Group type: EXPERIMENTAL
Intervention: Ibuprofen (600 mg orally three times a day after 30 mg ketorolac intravenously every 6 hours until able to take oral medications)
Number of subjects: 100

Group type: COMPARATOR
Intervention: Conventional treatment
Number of subjects: 100
Study: 11357169

Group type: EXPERIMENTAL
Intervention: Recombinant human interleukin-1 receptor antagonist (IL-1ra)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 7707057

Group type: EXPERIMENTAL
Intervention: Permethrin-treated military uniforms
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo-treated military uniforms
Number of subjects: 0
Study: 3300063

Group type: EXPERIMENTAL
Intervention: Insulin treatment
Number of subjects: 988

Group type: COMPARATOR
Intervention: Control group (non-insulinized patients)
Number of subjects: 988
Study: 30150152

Group type: EXPERIMENTAL
Intervention: Intraoperative periarticular injection (PAI) with liposomal bupivacaine (LB)
Number of subjects: 373

Group type: COMPARATOR
Intervention: Femoral nerve block (FNB)
Number of subjects: 373
Study: 26614123

Group type: COMPARATOR
Intervention: Clopidogrel (600 mg)
Number of subjects: 132

Group type: EXPERIMENTAL
Intervention: Prasugrel (60 mg)
Number of subjects: 132

Group type: EXPERIMENTAL
Intervention: Ticagrelor (180 mg)
Number of subjects: 132
Study: 26394352

Group type: EXPERIMENTAL
Intervention: Four-locator-retained mandibular overdentures
Number of subjects: 30

Group type: COMPARATOR
Intervention: Two-locator-retained mandibular overdentures
Number of subjects: 30
Study: 23939263

Group type: EXPERIMENTAL
Intervention: 100,000 U of oral cholecalciferol every 3 months for 1 year
Number of subjects: 159

Group type: COMPARATOR
Intervention: Matching placebo
Number of subjects: 159
Study: 21706359

Group type: EXPERIMENTAL
Intervention: Lapatinib plus capecitabine
Number of subjects: 22

Group type: COMPARATOR
Intervention: Lapatinib plus topotecan
Number of subjects: 22
Study: 18390643

Group type: EXPERIMENTAL
Intervention: Early AMD
Number of subjects: 1361

Group type: EXPERIMENTAL
Intervention: Late AMD
Number of subjects: 1361

Group type: EXPERIMENTAL
Intervention: Soft drusen
Number of subjects: 1361

Group type: EXPERIMENTAL
Intervention: Soft indistinct drusen
Number of subjects: 1361

Group type: EXPERIMENTAL
Intervention: Any pigmentary change
Number of subjects: 1361

Group type: COMPARATOR
Intervention: Alcohol consumption
Number of subjects: 1361
Study: 17165276

Group type: EXPERIMENTAL
Intervention: Ciclesonide 100 microg/d
Number of subjects: 145

Group type: EXPERIMENTAL
Intervention: Ciclesonide 200 microg/d
Number of subjects: 145

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 145
Study: 12614286

Group type: EXPERIMENTAL
Intervention: Corticosteroid withdrawal at day four post-transplantation (n = 40)
Number of subjects: 83

Group type: COMPARATOR
Intervention: Standard steroid therapy (n = 43)
Number of subjects: 83

Group type: EXPERIMENTAL
Intervention: Corticosteroid withdrawal group
Number of subjects: 83

Group type: COMPARATOR
Intervention: Standard steroid therapy group
Number of subjects: 83

Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 83
Study: 11030295

Group type: EXPERIMENTAL
Intervention: Acid infusion into the lower oesophagus
Number of subjects: 26

Group type: COMPARATOR
Intervention: Resting oesophageal pain threshold
Number of subjects: 26
Study: 10165095

Group type: EXPERIMENTAL
Intervention: Telephone-assisted weight-loss program (weekly calls)
Number of subjects: 64

Group type: COMPARATOR
Intervention: Minimal-contact group (no contact)
Number of subjects: 64
Study: 8115124

Group type: EXPERIMENTAL
Intervention: Cyclopentolate 1%
Number of subjects: 20

Group type: COMPARATOR
Intervention: Tropicamide 1%
Number of subjects: 20
Study: 3521526

Group type: EXPERIMENTAL
Intervention: Cefoperazone sodium plus mezlocillin sodium
Number of subjects: 41
Study: 29533358

Group type: EXPERIMENTAL
Intervention: Plyometric exercises including double‐leg hop, standing long jump, single‐leg standing long jump, bounding, skipping, power skipping, cone hops, and 45.72‐cm hurdle hops.
Number of subjects: 20

Group type: COMPARATOR
Intervention: Countermovement jump (for comparison).
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Plyometric exercises (various types).
Number of subjects: 20
Study: 29963818

Group type: EXPERIMENTAL
Intervention: Ketamine
Number of subjects: 120

Group type: EXPERIMENTAL
Intervention: Tramadol
Number of subjects: 120

Group type: EXPERIMENTAL
Intervention: Lidocaine
Number of subjects: 120

Group type: COMPARATOR
Intervention: Normal Saline (Placebo)
Number of subjects: 120
Study: 24755313

Group type: EXPERIMENTAL
Intervention: Noncalcified nodules (NCNs) observed on low-dose computed tomography (LDCT)
Number of subjects: 26272

Group type: EXPERIMENTAL
Intervention: Presence of ground-glass attenuation in NCNs
Number of subjects: 26272

Group type: EXPERIMENTAL
Intervention: Size of noncalcified nodules (NCNs)
Number of subjects: 26272
Study: 23001003

Group type: EXPERIMENTAL
Intervention: Intermittent isometric fatigue task at 60% of daily peak force
Number of subjects: 15

Group type: EXPERIMENTAL
Intervention: Intermittent isometric fatigue task at 70% of daily peak force
Number of subjects: 15

Group type: EXPERIMENTAL
Intervention: Perceived exertion and perceived task duration
Number of subjects: 15
Study: 21178138

Group type: EXPERIMENTAL
Intervention: VIR-576 (5.0 grams per day, intravenous infusion)
Number of subjects: 0
Study: 18081946

Group type: EXPERIMENTAL
Intervention: Medium carbonation (2.5 volumes)
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: High carbonation (3.7 volumes)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Low carbonation (1.7 volumes)
Number of subjects: 30
Study: 15990755

Group type: EXPERIMENTAL
Intervention: Statin therapy
Number of subjects: 163

Group type: COMPARATOR
Intervention: No statin therapy (Control)
Number of subjects: 163
Study: 12651043

Group type: EXPERIMENTAL
Intervention: Ticlopidine (500 mg) + Aspirin (100 mg)
Number of subjects: 700

Group type: COMPARATOR
Intervention: Clopidogrel (75 mg) + Aspirin (100 mg)
Number of subjects: 700
Study: 10821988

Group type: EXPERIMENTAL
Intervention: Buprenorphine (8 mg/day)
Number of subjects: 72

Group type: COMPARATOR
Intervention: Methadone (60 mg/day)
Number of subjects: 72

Group type: EXPERIMENTAL
Intervention: Both treatments
Number of subjects: 72

Group type: EXPERIMENTAL
Intervention: Buprenorphine
Number of subjects: 72
Study: 8695133

Group type: EXPERIMENTAL
Intervention: Supplemental O2 administered by bag‐valve‐mask during transport, followed by 40% face shield in the PACU
Number of subjects: 100

Group type: COMPARATOR
Intervention: Supplemental O2 by nasal cannula at 4 L/min during transport and PACU stay
Number of subjects: 100
Study: 8257839

Group type: EXPERIMENTAL
Intervention: Suo Quan pill
Number of subjects: 40

Group type: COMPARATOR
Intervention: Placebo (neutral pill)
Number of subjects: 40
Study: 3884080

Group type: EXPERIMENTAL
Intervention: Real ECT
Number of subjects: 19

Group type: COMPARATOR
Intervention: Simulated ECT
Number of subjects: 19
Study: 30614016

Group type: EXPERIMENTAL
Intervention: 585-nm PhotoLase laser
Number of subjects: 18

Group type: COMPARATOR
Intervention: 532-nm KTP laser
Number of subjects: 18

Group type: EXPERIMENTAL
Intervention: Comparison of adverse effects
Number of subjects: 18

Group type: EXPERIMENTAL
Intervention: Treatment speed
Number of subjects: 18
Study: 30028929

Group type: EXPERIMENTAL
Intervention: Light-cured anesthetic gel
Number of subjects: 82

Group type: COMPARATOR
Intervention: Placebo gel
Number of subjects: 82
Study: 27598511

Group type: EXPERIMENTAL
Intervention: 5‐mg VILD
Number of subjects: 16

Group type: COMPARATOR
Intervention: Placebo (PLBO)
Number of subjects: 16
Study: 25799858

Group type: EXPERIMENTAL
Intervention: Internet as a source of information about the impact of smoking on health
Number of subjects: 160

Group type: EXPERIMENTAL
Intervention: Internet as a source of information about the impact of alcohol on health
Number of subjects: 160

Group type: EXPERIMENTAL
Intervention: Internet as a source of information about the impact of energy drinks on health
Number of subjects: 160

Group type: EXPERIMENTAL
Intervention: Television as a source of information about the impact of smoking on health
Number of subjects: 160

Group type: EXPERIMENTAL
Intervention: Television as a source of information about the impact of alcohol on health
Number of subjects: 160

Group type: EXPERIMENTAL
Intervention: Television as a source of information about the impact of energy drinks on health
Number of subjects: 160
Study: 23064240

Group type: EXPERIMENTAL
Intervention: edoxaban 60 mg once daily × 7 days
Number of subjects: 48

Group type: EXPERIMENTAL
Intervention: digoxin 0.25 mg twice daily × 2 days and once daily × 5 days
Number of subjects: 48

Group type: EXPERIMENTAL
Intervention: edoxaban and digoxin coadministered for 7 days
Number of subjects: 48
Study: 20044531

Group type: EXPERIMENTAL
Intervention: tPA+TCD
Number of subjects: 416

Group type: EXPERIMENTAL
Intervention: tPA+TCCD
Number of subjects: 416

Group type: EXPERIMENTAL
Intervention: tPA+low-frequency ultrasound
Number of subjects: 416

Group type: COMPARATOR
Intervention: tPA alone
Number of subjects: 416

Group type: EXPERIMENTAL
Intervention: tPA+TCD/TCCD+/−microS
Number of subjects: 416

Group type: EXPERIMENTAL
Intervention: High-frequency ultrasound-enhanced thrombolysis
Number of subjects: 416
Study: 18320195

Group type: EXPERIMENTAL
Intervention: Water distension
Number of subjects: 83

Group type: COMPARATOR
Intervention: Air distension
Number of subjects: 83
Study: 15759817

Group type: EXPERIMENTAL
Intervention: Thymosin alpha-1 (T-alpha1) 1.6 mg subcutaneously twice weekly
Number of subjects: 56

Group type: EXPERIMENTAL
Intervention: Interferon-alpha (IFN-alpha) 5 million IU daily for 15 days, then thrice weekly for 6 months
Number of subjects: 56

Group type: COMPARATOR
Intervention: Historical control group (never treated with IFN-alpha)
Number of subjects: 56

Group type: EXPERIMENTAL
Intervention: Thymosin alpha-1 (T-alpha1)
Number of subjects: 56

Group type: EXPERIMENTAL
Intervention: Interferon-alpha (IFN-alpha)
Number of subjects: 56
Study: 12359680

Group type: EXPERIMENTAL
Intervention: Sertraline
Number of subjects: 134

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 134
Study: 10504127

Group type: EXPERIMENTAL
Intervention: AMICUS separator
Number of subjects: 21

Group type: COMPARATOR
Intervention: Spectra LRS separator
Number of subjects: 21
Study: 8708719

Group type: EXPERIMENTAL
Intervention: Western resection with limited (D1) lymphadenectomy
Number of subjects: 237

Group type: EXPERIMENTAL
Intervention: Japanese resection with extended lymphadenectomy (D2)
Number of subjects: 237

Group type: EXPERIMENTAL
Intervention: Japanese surgeon using conventional retrieval
Number of subjects: 237

Group type: EXPERIMENTAL
Intervention: Fat-clearance technique
Number of subjects: 237
Study: 1718251

Group type: EXPERIMENTAL
Intervention: Laser treatment of recurrent neovascularization
Number of subjects: 206

Group type: COMPARATOR
Intervention: No additional laser treatment
Number of subjects: 206
Study: 6344038

Group type: EXPERIMENTAL
Intervention: Diflunisal 500 mg
Number of subjects: 199

Group type: EXPERIMENTAL
Intervention: Diflunisal 1000 mg
Number of subjects: 199

Group type: EXPERIMENTAL
Intervention: Zomepirac sodium 100 mg
Number of subjects: 199

Group type: EXPERIMENTAL
Intervention: Aspirin 650 mg
Number of subjects: 199

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 199
Study: 29891331

Group type: EXPERIMENTAL
Intervention: Metformin treatment
Number of subjects: 149

Group type: EXPERIMENTAL
Intervention: High BDNF levels
Number of subjects: 149

Group type: EXPERIMENTAL
Intervention: CADP-CT >141 s
Number of subjects: 149

Group type: EXPERIMENTAL
Intervention: Adiponectin concentration >4.22 µg/mL
Number of subjects: 149

Group type: EXPERIMENTAL
Intervention: Total cholesterol and low-density lipoprotein levels
Number of subjects: 149
Study: 29958176

Group type: EXPERIMENTAL
Intervention: Radial approach
Number of subjects: 1107
Study: 27098538

Group type: EXPERIMENTAL
Intervention: Microbial cell preparation
Number of subjects: 40

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 40
Study: 24435414

Group type: EXPERIMENTAL
Intervention: HPV and cytology double testing
Number of subjects: 12527

Group type: COMPARATOR
Intervention: Cytology only
Number of subjects: 12527

Group type: EXPERIMENTAL
Intervention: HPV testing
Number of subjects: 12527

Group type: COMPARATOR
Intervention: Cytology
Number of subjects: 12527
Study: 23020264

Group type: EXPERIMENTAL
Intervention: Intravenous propofol (10 mg every 5‐10 minutes to a maximum of 80 mg, slowly)
Number of subjects: 90

Group type: COMPARATOR
Intervention: Intravenous dexamethasone (0.15 mg/kg to a maximum of 16 mg, slowly)
Number of subjects: 90
Study: 20863004

Group type: EXPERIMENTAL
Intervention: Esomeprazole 40 mg orally for 11 days
Number of subjects: 24

Group type: COMPARATOR
Intervention: Pantoprazole 40 mg orally for 11 days
Number of subjects: 24
Study: 17570119

Group type: EXPERIMENTAL
Intervention: Vicriviroc 5 mg
Number of subjects: 118

Group type: EXPERIMENTAL
Intervention: Vicriviroc 10 mg
Number of subjects: 118

Group type: EXPERIMENTAL
Intervention: Vicriviroc 15 mg
Number of subjects: 118

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 118
Study: 16009738

Group type: EXPERIMENTAL
Intervention: Hormone therapy (HT)
Number of subjects: 1160

Group type: COMPARATOR
Intervention: Non-hormone therapy (non-HT)
Number of subjects: 1160
Study: 12401613

Group type: COMPARATOR
Intervention: 2% lidocaine 40 mg (Group L)
Number of subjects: 176

Group type: EXPERIMENTAL
Intervention: Ephedrine 30 microg/kg (Group E30)
Number of subjects: 176

Group type: EXPERIMENTAL
Intervention: Ephedrine 70 microg/kg (Group E70)
Number of subjects: 176

Group type: EXPERIMENTAL
Intervention: Ephedrine 110 microg/kg (Group E110)
Number of subjects: 176

Group type: EXPERIMENTAL
Intervention: Ephedrine 150 microg/kg (Group E150)
Number of subjects: 176

Group type: COMPARATOR
Intervention: Saline placebo (Group P)
Number of subjects: 176
Study: 10201104

Group type: EXPERIMENTAL
Intervention: Positive and negative reinforcement with concurrent choice options including parent attention and preferred toys
Number of subjects: 2

Group type: EXPERIMENTAL
Intervention: Presentation of parent instructions in choice areas with parent attention
Number of subjects: 2